Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
September 19, 2003
Quantification of human brain benzodiazepine receptors using [18F]fluoroethylflumazenil: a first report in volunteers and epileptic patients
Philippe Levêque, Sandra Sanabria-Bohorquez, Anne Bol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2025
In Vivo Head-to-Head Comparison of [<sup>18</sup>F]GTP1 with [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]PI-2620 in Alzheimer Disease
Emily Olafson, Matteo Tonietto, Gregory Klein, et al.
Nuclear Medicine Communications
|
September 5, 2008
Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates
Marie-José Bélanger, Stephen M Krause, Christine Ryan, et al.
Journal of Alzheimer'S Disease : JAD
|
January 13, 2025
Cross-sectional and prognostic associations of baseline [<sup>18</sup>F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease
Nancy E Ruiz-Uribe, Paul Manser, Brandon Butcher, et al.
Alzheimer'S Research & Therapy
|
December 2, 2021
Baseline [<sup>18</sup>F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
Edmond Teng, Paul T Manser, Sandra Sanabria Bohorquez, et al.
Neurobiology of Aging
|
July 8, 2019
Cross-sectional associations between [<sup>18</sup>F]GTP1 tau PET and cognition in Alzheimer's disease
Edmond Teng, Michael Ward, Paul T Manser, et al.
Journal of Nuclear Medicine Technology
|
October 13, 2019
Optimization of <sup>89</sup>Zr PET Imaging for Improved Multisite Quantification and Lesion Detection Using an Anthropomorphic Phantom
Paul E Christian, Simon-Peter Williams, Lance Burrell, et al.
Investigational New Drugs
|
August 2, 2020
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors
Geoffrey I Shapiro, Patricia LoRusso, Daniel C Cho, et al.
JAMA Neurology
|
June 13, 2022
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
Edmond Teng, Paul T Manser, Karen Pickthorn, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
July 10, 2023
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies
Victor L Villemagne, Antoine Leuzy, Sandra Sanabria Bohorquez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
European Journal of Nuclear Medicine and Molecular Imaging
|
September 19, 2003
Quantification of human brain benzodiazepine receptors using [18F]fluoroethylflumazenil: a first report in volunteers and epileptic patients
Philippe Levêque, Sandra Sanabria-Bohorquez, Anne Bol, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2025
In Vivo Head-to-Head Comparison of [<sup>18</sup>F]GTP1 with [<sup>18</sup>F]MK-6240 and [<sup>18</sup>F]PI-2620 in Alzheimer Disease
Emily Olafson, Matteo Tonietto, Gregory Klein, et al.
Nuclear Medicine Communications
|
September 5, 2008
Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates
Marie-José Bélanger, Stephen M Krause, Christine Ryan, et al.
Journal of Alzheimer'S Disease : JAD
|
January 13, 2025
Cross-sectional and prognostic associations of baseline [<sup>18</sup>F]GTP1 tau PET signal and white matter lesion volumes for cognitive and functional decline in prodromal-to-mild Alzheimer's disease
Nancy E Ruiz-Uribe, Paul Manser, Brandon Butcher, et al.
Alzheimer'S Research & Therapy
|
December 2, 2021
Baseline [<sup>18</sup>F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer's disease
Edmond Teng, Paul T Manser, Sandra Sanabria Bohorquez, et al.
Neurobiology of Aging
|
July 8, 2019
Cross-sectional associations between [<sup>18</sup>F]GTP1 tau PET and cognition in Alzheimer's disease
Edmond Teng, Michael Ward, Paul T Manser, et al.
Journal of Nuclear Medicine Technology
|
October 13, 2019
Optimization of <sup>89</sup>Zr PET Imaging for Improved Multisite Quantification and Lesion Detection Using an Anthropomorphic Phantom
Paul E Christian, Simon-Peter Williams, Lance Burrell, et al.
Investigational New Drugs
|
August 2, 2020
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors
Geoffrey I Shapiro, Patricia LoRusso, Daniel C Cho, et al.
JAMA Neurology
|
June 13, 2022
Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
Edmond Teng, Paul T Manser, Karen Pickthorn, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
July 10, 2023
CenTauR: Toward a universal scale and masks for standardizing tau imaging studies
Victor L Villemagne, Antoine Leuzy, Sandra Sanabria Bohorquez, et al.
Page
of 2